{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:27:23Z","timestamp":1793647643806,"version":"4.5.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2504700"],"award-info":[{"award-number":["2022YFC2504700"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012152","name":"National Postdoctoral Program for Innovative Talents","doi-asserted-by":"publisher","award":["BX20230436"],"award-info":[{"award-number":["BX20230436"]}],"id":[{"id":"10.13039\/501100012152","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82221002"],"award-info":[{"award-number":["82221002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023M733948"],"award-info":[{"award-number":["2023M733948"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020795","name":"Outstanding Youth Scientist Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2021JJ10069"],"award-info":[{"award-number":["2021JJ10069"]}],"id":[{"id":"10.13039\/501100020795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jconrel.2025.01.001","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T14:27:43Z","timestamp":1736346463000},"page":"120-134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Size-specific clonidine-loaded liposomes: Advancing melanoma microenvironment suppression with safety and precision"],"prefix":"10.1016","volume":"379","author":[{"given":"Nianzhou","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yantao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeye","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maike","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingde","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.01.001_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jconrel.2025.01.001_bb0010","doi-asserted-by":"crossref","first-page":"364","DOI":"10.6004\/jnccn.2021.0018","article-title":"NCCN guidelines\u00ae insights: Melanoma: Cutaneous, Version 2.2021","volume":"19","author":"Swetter","year":"2021","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"10.1016\/j.jconrel.2025.01.001_bb0015","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.1200\/JCO.23.01136","article-title":"Systemic therapy for melanoma: ASCO guideline update","volume":"41","author":"Seth","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2025.01.001_bb0020","article-title":"A phase II study of efficacy and safety of the MEK inhibitor tunlametinib in patients with advanced NRAS-mutant melanoma","volume":"202","author":"Xiaoting","year":"2024","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jconrel.2025.01.001_bb0025","article-title":"Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for high-risk operable stage III melanoma: the phase II NeoACTIVATE trial","volume":"15","author":"Tina","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.01.001_bb0030","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41416-018-0327-z","article-title":"The clinical role of the TME in solid cancer","volume":"120","author":"Giraldo","year":"2019","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2025.01.001_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12102870","article-title":"Tumor microenvironment: implications in melanoma resistance to targeted therapy and immunotherapy","volume":"12","author":"Falcone","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jconrel.2025.01.001_bb0040","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12964-020-0530-4","article-title":"Tumor microenvironment complexity and therapeutic implications at a glance","volume":"18","author":"Baghban","year":"2020","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.jconrel.2025.01.001_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23094634","article-title":"Crosstalk between \u03b22- and \u03b12-adrenergic receptors in the regulation of B16F10 melanoma cell proliferation","volume":"23","author":"Matarrese","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2025.01.001_bb0050","doi-asserted-by":"crossref","first-page":"10535","DOI":"10.2147\/OTT.S264409","article-title":"\u03b12A-adrenergic receptor inhibits the progression of cervical Cancer through blocking PI3K\/AKT\/mTOR pathway","volume":"13","author":"Wang","year":"2020","journal-title":"Onco. Targets. Ther."},{"key":"10.1016\/j.jconrel.2025.01.001_bb0055","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41586-023-06110-8","article-title":"Tumour immune rejection triggered by activation of \u03b12-adrenergic receptors","volume":"618","author":"Zhu","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.01.001_bb0060","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cellsig.2017.03.003","article-title":"Alpha(2)-adrenoceptor agonists trigger prolactin signaling in breast cancer cells","volume":"34","author":"Castillo","year":"2017","journal-title":"Cell. Signal."},{"key":"10.1016\/j.jconrel.2025.01.001_bb0065","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1053\/jhep.2002.33330","article-title":"Stimulation of alpha2-adrenergic receptor inhibits cholangiocarcinoma growth through modulation of Raf-1 and B-Raf activities","volume":"35","author":"Kanno","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2025.01.001_bb0070","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1158\/0008-5472.CAN-05-4288","article-title":"Targeting oncogenes to improve breast cancer chemotherapy","volume":"66","author":"Christensen","year":"2006","journal-title":"Cancer Res."},{"issue":"Suppl 1","key":"10.1016\/j.jconrel.2025.01.001_bb0075","first-page":"S61","article-title":"Clonidine in the treatment of hypertension","volume":"2","author":"Bn","year":"1980","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.jconrel.2025.01.001_bb0080","article-title":"Evidence-based pharmacological treatment options for ADHD in children and adolescents","volume":"230","author":"Konstantin","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2025.01.001_bb0085","article-title":"A review of liposomes as a drug delivery system: current status of approved products, regulatory environments, and future perspectives","volume":"27","author":"Liu","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2025.01.001_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216397","article-title":"Nano-drug delivery system targeting tumor microenvironment: a prospective strategy for melanoma treatment","volume":"574","author":"Xu","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2025.01.001_bb0095","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2025.01.001_bb0100","doi-asserted-by":"crossref","first-page":"10938","DOI":"10.1021\/acs.chemrev.5b00046","article-title":"New developments in liposomal drug delivery","volume":"115","author":"Pattni","year":"2015","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2025.01.001_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113851","article-title":"Liposome composition in drug delivery design, synthesis, characterization, and clinical application","volume":"176","author":"Large","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.01.001_bb0110","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12943-023-01865-0","article-title":"Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation","volume":"22","author":"Chehelgerdi","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2025.01.001_bb0115","first-page":"293","article-title":"Nanomedicine in cancer therapy, signal transduction and targeted","volume":"8","author":"Fan","year":"2023","journal-title":"Therapy"},{"key":"10.1016\/j.jconrel.2025.01.001_bb0120","doi-asserted-by":"crossref","first-page":"13015","DOI":"10.1021\/acsnano.9b05679","article-title":"Overcoming the reticuloendothelial system barrier to drug delivery with a \u201cDon\u2019t-eat-us\u201d strategy","volume":"13","author":"Tang","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.01.001_bb0125","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1016\/j.apsb.2021.03.033","article-title":"Influencing factors and strategies of enhancing nanoparticles into tumors in vivo","volume":"11","author":"Zhang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2025.01.001_bb0130","doi-asserted-by":"crossref","first-page":"8151","DOI":"10.1021\/acs.nanolett.4c02114","article-title":"Cavitation-on-a-Chip enabled size-specific liposomal drugs for selective pharmacokinetics and pharmacodynamics","volume":"24","author":"Shan","year":"2024","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2025.01.001_bb0135","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.814","article-title":"Preclinical platforms to study therapeutic efficacy of human \u03b3\u03b4 T cells","volume":"12","author":"Ou","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.jconrel.2025.01.001_bb0140","doi-asserted-by":"crossref","first-page":"D1227","DOI":"10.1093\/nar\/gkad1040","article-title":"DGIdb 5.0: rebuilding the drug-gene interaction database for precision medicine and drug discovery platforms","volume":"52","author":"Cannon","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jconrel.2025.01.001_bb0145","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","article-title":"Pan-cancer Immunogenomic analyses reveal genotype-Immunophenotype relationships and predictors of response to checkpoint blockade","volume":"18","author":"Charoentong","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2025.01.001_bb0150","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s13059-016-1070-5","article-title":"Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression","volume":"17","author":"Becht","year":"2016","journal-title":"Genome Biol."},{"key":"10.1016\/j.jconrel.2025.01.001_bb0155","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41586-018-0694-x","article-title":"Lineage tracking reveals dynamic relationships of T cells in colorectal cancer","volume":"564","author":"Zhang","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.01.001_bb0160","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1476-5381.2011.01791.x","article-title":"Involvement of \u03b12- and \u03b22-adrenoceptors on breast cancer cell proliferation and tumour growth regulation","volume":"166","author":"P\u00e9rez Pi\u00f1ero","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jconrel.2025.01.001_bb0165","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s12668-022-00941-x","article-title":"A comprehensive review on novel liposomal methodologies, commercial formulations, clinical trials and patents","volume":"12","author":"Andra","year":"2022","journal-title":"Bionanoscience"},{"key":"10.1016\/j.jconrel.2025.01.001_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10020057","article-title":"Impact of particle size and polydispersity index on the clinical applications of Lipidic Nanocarrier systems","volume":"10","author":"Danaei","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.01.001_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2023.123756","article-title":"Long-term shelf-life liposomes for delivery of prednisolone and budesonide","volume":"394","author":"Budav\u00e1ri","year":"2024","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.jconrel.2025.01.001_bb0180","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.trecan.2017.09.006","article-title":"Migrating into the tumor: a roadmap for T cells","volume":"3","author":"van der Woude","year":"2017","journal-title":"Trends Cancer"},{"key":"10.1016\/j.jconrel.2025.01.001_bb0185","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jconrel.2023.02.006","article-title":"Skin drug delivery using lipid vesicles: a starting guideline for their development","volume":"355","author":"Guillot","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.01.001_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1248\/bpb.b16-00624","article-title":"Liposomal delivery systems: design optimization and current applications","volume":"40","author":"Abu Lila","year":"2017","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jconrel.2025.01.001_bb0195","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jconrel.2023.11.051","article-title":"OX40L-expressing M1-like macrophage exosomes for cancer immunotherapy","volume":"365","author":"Yu","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.01.001_bb0200","doi-asserted-by":"crossref","first-page":"2212118","DOI":"10.1002\/adfm.202212118","article-title":"An apoptotic body-based vehicle with navigation for Photothermal-immunotherapy by precise delivery and tumor microenvironment regulation","volume":"33","author":"Sheng","year":"2023","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2025.01.001_bb0205","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202004853","article-title":"Activating macrophage-mediated Cancer immunotherapy by genetically edited nanoparticles","volume":"32","author":"Rao","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.01.001_bb0210","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","article-title":"Liposomal drug delivery systems: from concept to clinical applications","volume":"65","author":"Allen","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.01.001_bb0215","doi-asserted-by":"crossref","first-page":"2103836","DOI":"10.1002\/advs.202103836","article-title":"Tumor-microenvironment-responsive nanomedicine for enhanced Cancer immunotherapy","volume":"9","author":"Peng","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2025.01.001_bb0220","doi-asserted-by":"crossref","first-page":"eaba9772","DOI":"10.1126\/scitranslmed.aba9772","article-title":"Reactivation of the tumor suppressor PTEN by mRNA nanoparticles enhances antitumor immunity in preclinical models","volume":"13","author":"Lin","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2025.01.001_bb0225","first-page":"297","article-title":"Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential","volume":"1","author":"Immordino","year":"2006","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.jconrel.2025.01.001_bb0230","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1021\/acs.nanolett.9b04024","article-title":"Self-propelled Gemini-like LMWH-scaffold Nanodrugs for overall tumor microenvironment manipulation via macrophage reprogramming and vessel normalization","volume":"20","author":"Xu","year":"2020","journal-title":"Nano Lett."}],"updated-by":[{"DOI":"10.1016\/j.jconrel.2025.02.041","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000}}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925000033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925000033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T12:25:28Z","timestamp":1762259128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925000033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":46,"alternative-id":["S0168365925000033"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.01.001","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Size-specific clonidine-loaded liposomes: Advancing melanoma microenvironment suppression with safety and precision","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}